{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:18:01Z","timestamp":1760548681310,"version":"build-2065373602"},"reference-count":39,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.tox.2008.06.006","type":"journal-article","created":{"date-parts":[[2008,6,26]],"date-time":"2008-06-26T04:54:42Z","timestamp":1214456082000},"page":"100-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Role of biotransformation in 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione-induced hepatotoxicity in Fischer 344 rats"],"prefix":"10.1016","volume":"250","author":[{"given":"Christine M.","family":"Crincoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Niti N.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruy","family":"Tchao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Harvison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tox.2008.06.006_bib1","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1021\/tx050353h","article-title":"Thiazolidinedione bioactivation: a comparison of the bioactivation potentials of troglitazone, rosiglitazone and pioglitazone using stable isotope-labeled analogues and liquid chromatography tandem mass spectrometry","volume":"19","author":"Alv\u00e1rez-Sanchez","year":"2006","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tox.2008.06.006_bib2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/0076-6879(91)06114-I","article-title":"Measurement of steroid hydroxylation reactions by high-performance liquid chromatography as indicator of P450 identity and function","volume":"206","author":"Arlotto","year":"1991","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.tox.2008.06.006_bib3","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1124\/dmd.104.002683","article-title":"Metabolic activation of pioglitazone identified from rat and human liver microsomes and freshly isolated hepatocytes","volume":"33","author":"Baughman","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2008.06.006_bib4","first-page":"248","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Chem."},{"key":"10.1016\/j.tox.2008.06.006_bib5","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0968-0896(01)00366-2","article-title":"Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones","volume":"10","author":"Bruno","year":"2002","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.tox.2008.06.006_bib6","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0006-2952(94)90363-8","article-title":"Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver","volume":"48","author":"Burke","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.tox.2008.06.006_bib7","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0090-9556(25)07555-5","article-title":"cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus","volume":"22","author":"Buters","year":"1994","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2008.06.006_bib8","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/jbt.20103","article-title":"Quantification of the expression and inducibility of 12 rat cytochrome P450 isoforms by quantitative RT-PCR","volume":"19","author":"Caron","year":"2005","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.tox.2008.06.006_bib9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/hep.20567","article-title":"Troglitazone and liver injury: in search of answers","volume":"41","author":"Chojkier","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.tox.2008.06.006_bib10","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1080\/01926230590522428","article-title":"Mechanistic classification of liver injury","volume":"33","author":"Cullen","year":"2005","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.tox.2008.06.006_bib11","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1271\/bbb1961.35.1707","article-title":"Antimicrobial activity of 3-phenyloxazolidine-2,4-diones and related compounds","volume":"35","author":"Fujinami","year":"1971","journal-title":"Agric. Biol. Chem."},{"key":"10.1016\/j.tox.2008.06.006_bib12","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/S0140-6736(00)04960-6","article-title":"Lessons from the glitazones: a story of drug development","volume":"357","author":"Gale","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.tox.2008.06.006_bib13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.7326\/0003-4819-129-1-199807010-00008","article-title":"Two cases of severe clinical and histologic hepatotoxicity associated with troglitazone","volume":"129","author":"Gitlin","year":"1998","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tox.2008.06.006_bib14","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0002-9343(01)00926-3","article-title":"Liver failure in a patient treated with long-term rosiglitazone therapy","volume":"111","author":"Gouda","year":"2001","journal-title":"Am. J. Med."},{"key":"10.1016\/j.tox.2008.06.006_bib15","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1124\/dmd.32.6.639","article-title":"Metabolic activation of troglitazone: identification of a reactive metabolite and mechanisms involved","volume":"32","author":"He","year":"2004","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.tox.2008.06.006_bib16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1021\/tx000180q","article-title":"Studies on the metabolism of troglitazone to reactive intermediates in vitro and in vivo. Evidence for novel biotransformation pathways involving quinine methide formation and thiazolidinedione ring scission","volume":"14","author":"Kassahun","year":"2001","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tox.2008.06.006_bib17","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/0378-4274(92)90245-F","article-title":"Sex-specific cytochrome as a cause of sex- and species-related differences in drug toxicity","volume":"64\/65","author":"Kato","year":"1992","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.tox.2008.06.006_bib18","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0300-483X(02)00692-3","article-title":"Nephrotoxic and hepatotoxic potential of imidazolidinedione-, oxazolidinedione-, and thiazolidinedione-containing analogues of N-(3,5-dichlorophenyl)succinimide (NDPS) in Fischer 344 rats","volume":"186","author":"Kennedy","year":"2003","journal-title":"Toxicology"},{"key":"10.1016\/j.tox.2008.06.006_bib19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/j.1572-0241.2000.01707.x","article-title":"Hepatotoxicity due to troglitazone: Report of two cases and review of adverse events reported to the United States Food and Drug Administration","volume":"95","author":"Kohlroser","year":"2000","journal-title":"Am. J. Gasteroenterol."},{"key":"10.1016\/j.tox.2008.06.006_bib20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1006\/taap.1996.8081","article-title":"Role of CYP3A in ethanol-mediated increases in acetaminophen hepatotoxicity","volume":"143","author":"Kostrubsky","year":"1997","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2008.06.006_bib21","series-title":"Biochemical Toxicology: A Practical Approach","first-page":"183","article-title":"Preparation and characterization of microsomal fractions for studies on xenobiotic metabolism","author":"Lake","year":"1987"},{"key":"10.1016\/j.tox.2008.06.006_bib22","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1021\/tx0340302","article-title":"Gender differences in microsomal metabolic activation of hepatotoxic clivorine in rat","volume":"16","author":"Lin","year":"2003","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tox.2008.06.006_bib23","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0306-3623(96)00183-8","article-title":"Zonation of cytochrome P450 expression, drug metabolism and toxicity in liver","volume":"28","author":"Lindros","year":"1997","journal-title":"Gen. Pharmacol."},{"key":"10.1016\/j.tox.2008.06.006_bib24","doi-asserted-by":"crossref","first-page":"306","DOI":"10.7326\/0003-4819-135-4-200108210-00029","article-title":"Hepatocelluar injury in a patient receiving pioglitazone","volume":"135","author":"Maeda","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tox.2008.06.006_bib25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2133\/dmpk.21.347","article-title":"Metabolic and non-metabolic factors determining troglitazone hepatotoxicity: a review","volume":"21","author":"Masubuchi","year":"2006","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.tox.2008.06.006_bib26","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0272-0590(92)90026-E","article-title":"1-Aminobenzotriazole-induced destruction of hepatic and renal cytochromes P450 in male Sprague-Dawley rats","volume":"19","author":"Mugford","year":"1992","journal-title":"Fundam. Appl. Toxicol."},{"key":"10.1016\/j.tox.2008.06.006_bib27","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1191\/096032700678815648","article-title":"Glucocorticoid-dependent maintenance of CYP2C11-dependent oxidation in male rat liver in vivo","volume":"19","author":"Murray","year":"2000","journal-title":"Human Exp. Toxicol."},{"key":"10.1016\/j.tox.2008.06.006_bib28","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/toxsci\/kfl180","article-title":"Troglitazone-induced hepatic necrosis in an animal model of silent genetic mitochondrial abnormalities","volume":"97","author":"Ong","year":"2007","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.tox.2008.06.006_bib29","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1080\/00498250701830267","article-title":"Effect of gender, dose and time on 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione (DCPT)-induced hepatotoxicity in Fischer 344 rats","volume":"38","author":"Patel","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1016\/j.tox.2008.06.006_bib30","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.bmc.2005.08.056","article-title":"In vitro aldose reductase inhibitory activity of 5-benzyl-2,4-thiazolidinediones","volume":"14","author":"Rakowitz","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.tox.2008.06.006_bib31","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1021\/tx0500373","article-title":"Mechanistic studies on the metabolic scission of thiazolidinedione derivatives to acyclic thiols","volume":"18","author":"Reddy","year":"2005","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tox.2008.06.006_bib32","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2165\/00002018-200124120-00002","article-title":"Hepatotoxicity with thiazolidinediones: is it a class effect?","volume":"24","author":"Scheen","year":"2001","journal-title":"Drug Saf."},{"key":"10.1016\/j.tox.2008.06.006_bib33","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1021\/tx034033e","article-title":"Mechanisms of troglitazone hepatotoxicity","volume":"16","author":"Smith","year":"2003","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tox.2008.06.006_bib34","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/0041-008X(91)90010-C","article-title":"The acute hepatotoxicity of the isomers of dichlorobenzene in Fischer-344 and Sprague-Dawley rats: isomer-specific and strain-specific differential toxicity","volume":"109","author":"Stine","year":"1991","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.tox.2008.06.006_bib35","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0090-9556(24)14912-4","article-title":"Studies on cytochrome P-450-mediated biotransformation of diclofenac in rats and in human hepatocytes: identification of glutathione conjugated metabolites","volume":"27","author":"Tang","year":"1999","journal-title":"Drug. Metab. Dispos."},{"key":"10.1016\/j.tox.2008.06.006_bib36","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1021\/tx0001981","article-title":"Enzyme-induction dependent bioactivation of troglitazone and troglitazone quinone in vivo","volume":"14","author":"Tettey","year":"2001","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.tox.2008.06.006_bib37","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00000433-200109000-00024","article-title":"Hepatic glycogen staining. Applications in injury survival time and child abuse","volume":"22","author":"Thogmartin","year":"2001","journal-title":"Am. J. Forensic Med. Pathol."},{"key":"10.1016\/j.tox.2008.06.006_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jat.2550130103","article-title":"Acute hepatic and renal toxicity of dichlorobenzene isomers in Fischer 344 rats","volume":"13","author":"Valentovic","year":"1993","journal-title":"J. Appl. Toxicol."},{"key":"10.1016\/j.tox.2008.06.006_bib39","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1177\/00912700122012724","article-title":"Human drug metabolism and the cytochromes P450: Application and relevance of in vitro models","volume":"41","author":"Venkatakrishnan","year":"2001","journal-title":"J. Clin. Pharmacol."}],"container-title":["Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X08002710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300483X08002710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T23:02:06Z","timestamp":1759532526000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300483X08002710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":39,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0300483X08002710"],"URL":"https:\/\/doi.org\/10.1016\/j.tox.2008.06.006","relation":{},"ISSN":["0300-483X"],"issn-type":[{"type":"print","value":"0300-483X"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of biotransformation in 3-(3,5-dichlorophenyl)-2,4-thiazolidinedione-induced hepatotoxicity in Fischer 344 rats","name":"articletitle","label":"Article Title"},{"value":"Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tox.2008.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}